ClinConnect ClinConnect Logo
Search / Trial NCT05139589

The ENDOCARDITIS AUMC Data Collection

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Nov 30, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The ENDOCARDITIS AUMC Data Collection trial is studying patients with a heart condition called infective endocarditis, which is an infection of the heart valves. The researchers want to compare these patients, who need valve surgery, with those who are having similar surgery for other non-infectious reasons. The goal is to find ways to improve care for these high-risk patients during and after their surgery.

To be eligible for this study, participants must be at least 18 years old, speak either Dutch or English, and be admitted to the Amsterdam UMC for infective endocarditis. This includes patients who are scheduled for heart valve surgery because of the infection, as well as a similar group of patients undergoing surgery for other reasons. However, individuals with a history of blood clotting disorders cannot participate. Those who join the study can expect to provide information about their health and treatment, helping researchers understand how to better manage care for these serious heart conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients \> 18 years
  • Dutch or English speaking
  • All patients with infective endocarditis admitted to Amsterdam UMC in the study period
  • All patients with infective endocarditis scheduled for cardiac valve surgery compared to a matched cohort of patients scheduled for similar surgery due to non-infectious indication in Amsterdam UMC in the same period
  • Exclusion Criteria:
  • Previous history of coagulation disorders

About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)

The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.

Locations

Amsterdam, North Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Markus W Hollmann, MD,PhD,PhD

Principal Investigator

Amsterdam Academic Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials